CC
SSAAW

Covalis Capital’s Science Strategic Acquisition Corp. Alpha Warrant SSAAW Stock Holding History

Covalis Capital’s Portfolio SSAAW Stock Details SSAAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-23,332
Closed -$91K – 101
2021
Q4 		$91K Hold
23,332
– – 0.03% 74
2021
Q3 		$97K Hold
23,332
– – 0.02% 108
2021
Q2 		$101K Buy
+23,332
New +$17.6K 0.03% 111

Other funds holding SSAAW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
GL
Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Covalis Capital's SSAAW Position: Q1 2022 in Review

Covalis Capital sold out of Science Strategic Acquisition Corp. Alpha Warrant (SSAAW) in Q1 2022, closing a stake of 23,332 shares — an estimated $91K sold.

Covalis Capital first reported a position in SSAAW in Q2 2021 and held it in 3 quarters. The position peaked at $101K in Q2 2021. 63 funds tracked by Wall St. Rank hold SSAAW as of Q1 2022.

  • Covalis Capital reported no remaining Science Strategic Acquisition Corp. Alpha Warrant position as of Q1 2022 after selling out during the quarter.
  • Covalis Capital sold 23,332 Science Strategic Acquisition Corp. Alpha Warrant shares in Q1 2022, an estimated $91K.
  • Covalis Capital first reported a position in Science Strategic Acquisition Corp. Alpha Warrant in Q2 2021 and held it in 3 quarters.
  • Covalis Capital's Science Strategic Acquisition Corp. Alpha Warrant position peaked at $101K in Q2 2021.
  • 63 funds tracked by Wall St. Rank held Science Strategic Acquisition Corp. Alpha Warrant as of Q1 2022.

Based on Covalis Capital's 13F filing for Q1 2022, filed 16 May 2022.